 IRVINE, CA, Oct. 19, 2021 GLOBE NEWSWIRE -- Odyssey Group International, Inc. OTC:ODYY the Company or Odyssey, a medical technology company focused on developing unique, life-saving medical products, today announced the filing of a provisional patent on its novel nasal drug delivery device. The device and drug combination will be used in Odysseys sponsored current clinical trial for treating concussion. 